Niacin And Laropiprant Combo Shows No Benefits, Has Some Harmful Effects In Patients With Vascular Disease

A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented at the American College of Cardiology’s 62nd Annual Scientific Session. Detailed trial data is presented here for the first time…

The Importance Of Monitoring Vitamin D Levels In All Patients With Cirrhosis

Vitamin D deficiency is a well reported complication in chronic cholestatic liver disease such as primary biliary cirrhosis. While the prevalence and treatment of this deficiency has been addressed in many articles over the last decades, little is known of the vitamin D status in alcoholic liver cirrhosis…

« Previous Page